| AMPK | AMP-activated protein kinase |
| ANOVA | Analysis of variance |
| COMB | Combination group |
| CTRL | Placebo group |
| FDA | Food and Drug Administration |
| FLU | Fluvastatin group |
| FMD | Flow mediated dilation |
| hTERT | human telomerase reverse transcriptase |
| MILES | Metformin in Longevity Study |
| mTOR | Mechanistic target of rapamycin |
| NAD | Nicotinamide adenine dinucleotide |
| NF-κB1 | Nuclear factor κB |
| NFE2L2 | Nuclear factor (erythroid-derived 2)-like 2 gene |
| PRKAA | 5′-AMP-activated protein kinase catalytic subunit α-2 gene |
| PWV | Pulse wave velocity |
| qPCR | Quantitative real-time polymerase chain reaction |
| SIRT1 | Sirtuin 1 gene |
| VAL | Valsartan group |